| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/02/2002 | CN1329152A A novel polypeptide-human steroid reducing enzyme 15.73 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329151A A novel polypeptide-human steroid reducing enzyme 11.66 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329150A A novel polypeptide-NAD-dependent 2-hydroxy acid dehydrogenase family protein 11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329149A A novel polypeptide-aldehyde/ketone reducing enzyme 15 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329148A A novel polypeptide-human NADH dehydrogenase subunit I-9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329147A A novel polypeptide-hydrogen peroxidase 9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329146A A novel polypeptide-nucleotide reducing enzyme 10.49 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329145A A novel polypeptide-DNA polymerase 10 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329144A A novel polypeptide-human aminoacyl-tRNA synthetase 29 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329143A A novel polypeptide-human mitochondrial polymerase 14.3 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329142A A novel polypeptide-RNA polymerase II related protein 11.33 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329140A A novel polypeptide-human mitochondrial polymerase 13.86 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329092A A novel polypeptide-human RS3 protien 18 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329091A A novel polypeptide-human tropobidin 9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329090A A novel polypeptide-human autoimmune disease related protein 10 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329089A A novel polypeptide-human milk gland susceptible gene coding protein 12.32 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329086A A novel polypeptide-human TNFR/NGFR protein 15 contaiing cytochrome C structural domain and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329074A A novel polypeptide-human fascicled and extension protein 12.87 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329073A A novel polypeptide - human fasciculation and elongation protein 16.61 and a polynucleotide encoding the same |
| 01/02/2002 | CN1329069A A novel polypeptide-human PLP protein 39 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329067A A novel polypeptide-human latexin protein 53 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329057A A novel polypeptide-human MBLL zinc finger protein 39 and polynucletoide for coding this polypeptide |
| 01/02/2002 | CN1329054A A novel polypeptide-human cell death related protein 9.46 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329045A A novel polypeptide-mouse zinc finger protein (Zfp-1) protein 16 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329044A A novel polypeptide-human shearing factor 9.24 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329043A A novel polypeptide-human L1 factor ORF2 inversed transcriptive related protein 15 and plynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329042A A novel polypeptide-human zinc finger protein FPM 315-17 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329040A A novel polypeptide-human L1 factor ORF2 inversed transcriptive related protein 13 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329038A A novel polypeptide-human ribonucleoside diphosphate kinase arrestin 10.23 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329031A A novel polypeptide-human RNA conjugated protein 19 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329028A A novel polypeptide-human L1 factor ORF2 inversed transcriptive related protein 11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329027A A novel polypeptide-human lymph enhancer 42 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329024A A novel polypeptide-activating GTP enzyme protein negative regulatory factor 11.66 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329020A A novel polypeptide-acid phosphatase family protein 11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329018A A novel polypeptide-phytochrome 9.9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329012A A novel polypeptide-nicotinamide adenine deoxydinucleotide dependent leukotriene B412-hydroxydehydrogenase 36 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329011A A novel polypeptide-mouse transient receptor potential protein 2(Trp2)12 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329009A A novel polypeptide-avidin 9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329008A A novel polypeptide-H1yD protein family secretory protein 11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1328848A Bimaxiancao capsule and its preparation method |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335436 Antisense oligonucleotide coupled to ligand such as d-cycloserine, d-glucosamine, or biotin which binds to receptor on mycobacterium; hybridizes to aspartokinase or aspartate semialdehyde dehydrogenase genes |
| 01/01/2002 | US6335433 nrdD |
| 01/01/2002 | US6335427 Component of stem bromelain |
| 01/01/2002 | US6335426 T-cell selective interleukin-4 agonists |
| 01/01/2002 | US6335424 ribG |
| 01/01/2002 | US6335360 Indoline-2-carboxylic amide derivatives; obesity, eating and psychological disorders |
| 01/01/2002 | US6335321 Non-steroidal anti-inflammatory agent therapy for epithelial cell cancer |
| 01/01/2002 | US6335320 Method of treating fibrotic conditions |
| 01/01/2002 | US6335319 Treatment of obesity |
| 01/01/2002 | US6335318 Antimicrobial theta defensins and methods of using same |
| 01/01/2002 | US6335317 Administering fibroblast growth factor to reduce gastrointestinal tract oxidative damage from malnutrition, fasting, toxicity, chemotherapy, alcoholism, irradiation therapy |
| 01/01/2002 | US6335316 Method for administering acylated insulin |
| 01/01/2002 | US6335195 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/01/2002 | US6335194 Antisense modulation of survivin expression |
| 01/01/2002 | US6335181 Generating polypeptide; for use in the diagnosis, prevention and treatment of bacterial infection |
| 01/01/2002 | US6335180 Nucleic acid sequences encoding capsaicin receptor and uses thereof |
| 01/01/2002 | US6335174 Oncofetal antigen specific t-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10 |
| 01/01/2002 | US6335172 Cloned tetrodotoxin-sensitive sodium channel α-subunit and a splice variant thereof |
| 01/01/2002 | US6335163 Aggolomeration of receptor proteins; for use in diagnosis, treatment, and prevention of tumors, parasitic, bacterial and viral infections; for use in gene therapy |
| 01/01/2002 | US6335160 Methods and compositions for polypeptide engineering |
| 01/01/2002 | US6335159 Retinoic acid receptor ε(rarε) |
| 01/01/2002 | US6335156 Screening for anticarcinogenic/antitumor agents; incubate cells with antitumor agent, monitor cells for expression of reporter molecules |
| 01/01/2002 | US6335020 Allergenic peptides from ragweed pollen |
| 01/01/2002 | US6335019 Methods for treating sensitivity to protein allergen using peptides which include a T cell epitope recognized by a T cell receptor specific for the protein allergen |
| 01/01/2002 | US6335017 Compositions and methods for treating viral infections |
| 01/01/2002 | US6335013 Methods and materials relating to CD39-like polypeptides |
| 01/01/2002 | US6335012 Delivering lytic enzyme able to digest cell wall of bacteria and toothpaste, oral wash, chewing gum, and lozenge; anticaries agents |
| 01/01/2002 | US6335011 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions to treat lysosomal storage disease |
| 01/01/2002 | US6335010 Gene therapy in coronary angioplasty and bypass |
| 01/01/2002 | US6335006 Applying loosening solution of hyaluronidase, separating tissues |
| 01/01/2002 | US6334996 Radiolabels for targeting specific diagnostic pharmaceuticals |
| 01/01/2002 | CA2235626C Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 01/01/2002 | CA2181477C Analogs of thymosin .alpha.1 |
| 01/01/2002 | CA2099529C Antemortem nutrient supplement for livestock |
| 01/01/2002 | CA2097192C Bombesin antagonists |
| 01/01/2002 | CA2068327C Polypeptide and anti-hiv drug prepared therefrom |
| 01/01/2002 | CA2048544C Intravascular embolizing agent containing angiogenesis-inhibiting substance |
| 01/01/2002 | CA2026376C Anticoagulant peptides |
| 01/01/2002 | CA1341330C Substituted acyl dertivatives of 1,2,3,4-tetrahydroisquinoline-3-carboxylic acids |
| 12/29/2001 | CA2351904A1 Target |
| 12/29/2001 | CA2351897A1 Use of growth hormone secretagogues for treatment of physical performance decline |
| 12/27/2001 | WO2001098536A2 METHOD FOR ACTIVATING PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-$g(g) |
| 12/27/2001 | WO2001098522A2 Positively-charged peptide nucleic acid analogs with improved properties |
| 12/27/2001 | WO2001098520A1 Transgenically produced platelet derived growth factor |
| 12/27/2001 | WO2001098515A2 Gene-regulating conjugates |
| 12/27/2001 | WO2001098512A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 12/27/2001 | WO2001098511A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 12/27/2001 | WO2001098506A2 Methods and means for regulation of gene expression |
| 12/27/2001 | WO2001098503A2 Regulation of human eosinophil serine protease 1-like enzyme |
| 12/27/2001 | WO2001098500A1 Receptor binding molecules |
| 12/27/2001 | WO2001098497A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | WO2001098496A1 Mammastatin sequence variant c |
| 12/27/2001 | WO2001098495A1 Novel protein and dna thereof |
| 12/27/2001 | WO2001098494A1 Ligand to gpr8 and dna thereof |
| 12/27/2001 | WO2001098493A1 Insulin-like growth factor-binding protein |
| 12/27/2001 | WO2001098491A2 Osteolevin gene polymorphisms |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098489A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus |